449 Recruiting Trials

Clinical Trials
for Cancer in Washington

449 clinical trials for Cancer are currently recruiting participants at study sites in Washington. Study-related care is provided at no cost.

449
Recruiting trials
331
Study sites
45
Cities
275
Industry-sponsored
177
Phase 2
149
Phase 3

Cancer clinical trials in Washington: what to expect

Cancer is the single largest area of clinical research, and nearly every recruiting cancer trial is written for one cancer type at one stage. Most test a new drug or combination against the current standard treatment: targeted medicines matched to a mutation found in the tumor, immunotherapies that help the immune system recognize cancer cells, antibody-drug conjugates and cell therapies. Others study surgery and radiation techniques, ways to reduce side effects, and screening or prevention in people at higher risk.

In Washington, recruiting cancer studies are concentrated in Seattle, Spokane, Vancouver and Tacoma, with sites in 41 other cities. 275 of the 449 are run by a drug or device company, which usually means a larger study with travel reimbursement; the rest are academic or hospital-led.

Who cancer trials usually look for

Every listing names the cancer type and stage it enrolls, and most also state how many earlier treatments you may have had: some are for people newly diagnosed, many are for cancer that has come back or spread after a first treatment stopped working. Targeted-therapy trials require a specific result on tumor testing, which the site can arrange if it has not been done. Trials generally ask that you are well enough for daily activity (a "performance status" the doctor scores), that blood counts and liver and kidney function are adequate, and that a few weeks have passed since your last treatment.

Having advanced or metastatic cancer does not rule you out. A large share of recruiting trials are designed specifically for it.

What taking part involves

Screening reviews your pathology and scans, often with new blood work and sometimes a fresh biopsy. Treatment then follows a cycle, typically every two or three weeks, with scans every six to twelve weeks to measure the response. Early-phase trials have more frequent visits at the start. The study drug and study-specific tests are provided at no cost; standard care that you would receive anyway is usually billed to insurance as normal. A placebo on its own is rare in cancer trials: when there is one, it is added to the standard treatment, and the consent form says so.

Questions worth asking the study team

Whether the trial is randomized and what the comparison treatment is; what happens if the cancer grows during the study; whether you can keep receiving the drug afterward if it is working; how the trial fits with the plan your own oncologist has suggested; and what travel or lodging support is offered. Your oncologist can also refer you directly.

Showing 20 of 449 recruiting Cancer trials in Washington

Pan Tumor Rollover Study
PHASE2 Huntsville, Alabama +4 sites NCT03899155
This trial is looking for patients with cancer who have had a good response to previous treatments. Participants will continue receiving nivolumab alone or in combination with other cancer therapies to study long-term safety.
Recruiting
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
PHASE2 San Francisco, California +4 sites NCT05783323
This trial is looking for patients with differentiated thyroid cancer to take part in a study using the drug larotrectinib. Participants will need to meet certain health criteria and will be monitored during the treatment.
Recruiting
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
PHASE2 Seattle, Washington +4 sites NCT06458036
This trial is looking for young patients aged 2 to 25 who have been diagnosed with certain types of thyroid cancer and have had surgery. Participants will receive a treatment called selpercatinib before traditional radioactive iodine therapy.
Recruiting
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1 Stanford, California +4 sites NCT03686124
This trial is looking for patients with certain types of cancer that keep coming back or do not respond to standard treatments. Participants will receive the study treatment IMA203/IMA203CD8, either alone or with nivolumab.
Recruiting
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
PHASE2 Little Rock, Arkansas +4 sites NCT05997017
This trial is looking for women with advanced or recurrent endometrioid endometrial cancer to test a combination of two medications. Participants must have measurable disease and meet certain health criteria to join the study.
Recruiting
A Tailored Medication Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer
NA Seattle, Washington +3 sites NCT07223463
This trial is looking for young people aged 15 to 24 who have been diagnosed with cancer. Participants will use an electronic device to help manage their medications and take part in sessions to improve their medication routines.
Recruiting
Resilience Mobile App for Teens and Young Adults With Cancer
NA Seattle, Washington NCT05842902
This trial is looking for teens and young adults aged 12 to 25 who have been diagnosed with cancer within the last year. Participants will use a mobile app designed to improve mental health and quality of life during their cancer treatment.
Recruiting
Childhood Cancer Survivor Study
N/A Birmingham, Alabama +4 sites NCT01120353
This trial is looking for childhood cancer survivors who were diagnosed before age 21 and survived for at least five years. Participants will be followed to understand the long-term effects of their cancer treatments.
Recruiting
A Crowd Sourcing Platform for Patients With Cancer
N/A Seattle, Washington NCT03530826
This trial is looking for cancer patients who want to share their experiences and information with others. Participants will help contribute to understanding and research on cancer through the All4Cure website.
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Birmingham, Alabama +4 sites NCT06058377
This trial is looking for women with hormone receptor positive, HER2 negative stage II-III breast cancer. Participants will receive standard chemotherapy along with an immunotherapy drug called durvalumab to see if it helps prevent cancer from coming back.
Recruiting
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
PHASE3 Beverly Hills, California +4 sites NCT06472245
This trial is looking for adults with advanced non-small cell lung cancer who have not responded to previous immune therapy. Participants will receive either the experimental treatment OSE2101 or standard treatment with docetaxel.
Recruiting
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer
PHASE3 Mobile, Alabama +4 sites NCT06510374
This trial is looking for people with intermediate risk non-muscle invasive bladder cancer. Participants will either receive a treatment called Nadofaragene Firadenovec or be monitored without treatment.
Recruiting
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder Cancer
PHASE3 Tucson, Arizona +4 sites NCT06545955
This trial is looking for adults with a specific type of bladder cancer called carcinoma in situ (CIS) who have not responded to previous treatments. Participants will receive a treatment called nadofaragene firadenovec, either alone or with other therapies, to see how well it works.
Recruiting
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
PHASE3 Fairbanks, Alaska +4 sites NCT06758401
This trial is looking for people with advanced lung cancer who have high levels of a specific protein called PD-L1. Participants will receive a combination treatment of two medications or just one and will be monitored regularly at a clinic.
Recruiting
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer
PHASE3 Orlando, Florida +4 sites NCT06915025
This trial is looking for women aged 18 and older who have been diagnosed with advanced ovarian, fallopian tube, or peritoneal cancer. Participants will receive a new treatment called IMNN-001 along with standard chemotherapy to see how effective and safe it is.
Recruiting
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
PHASE3 Olympia, Washington +4 sites NCT07775287
This trial is looking for people with colorectal cancer that has come back or spread and cannot be removed by surgery. Participants will take either petosemtamab with chemotherapy or standard treatment options with chemotherapy, with regular visits for testing.
Recruiting
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
PHASE3 Birmingham, Alabama +4 sites NCT06216301
This trial is looking for adults with advanced non-small cell lung cancer that has spread. Participants will receive TTFields, a therapy delivered by a device, along with standard chemotherapy and pembrolizumab, an immune treatment.
Recruiting
A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
PHASE3 Daphne, Alabama +4 sites NCT06646276
This trial is looking for people with extensive-stage small cell lung cancer. Participants will receive one of two different treatment combinations and will be monitored for their health and tumor response.
Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
PHASE3 Chandler, Arizona +4 sites NCT07291037
This trial is looking for patients with advanced lung cancer that tests positive for a specific protein. Participants will receive either datopotamab deruxtecan or docetaxel as treatment.
Recruiting
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
PHASE3 Newport Beach, California +4 sites NCT07419295
This trial is looking for people with bladder cancer that has spread or got worse after previous treatments. Participants will receive a new treatment called sacituzumab tirumotecan and be compared to those receiving standard chemotherapy options.
Recruiting

Where the Cancer studies are in Washington

  • Fred Hutchinson Cancer Center, Seattle81 trials
  • Swedish Medical Center-First Hill, Seattle48 trials
  • Fred Hutch/University of Washington Cancer Consortium, Seattle44 trials
  • Swedish Cancer Institute-Edmonds, Edmonds43 trials
  • Swedish Cancer Institute-Issaquah, Issaquah42 trials
  • Kadlec Clinic Hematology and Oncology, Kennewick33 trials

Counts are recruiting studies listing at least one site in Washington, from ClinicalTrials.gov, refreshed every two days.

Cancer clinical trials in Washington: common questions

How many Cancer clinical trials are recruiting in Washington?
TrialFinder currently lists 449 recruiting Cancer clinical trials with study sites in Washington. Results are updated regularly from ClinicalTrials.gov, the official U.S. registry of clinical studies.
Where are Cancer clinical trials located in Washington?
Study sites for the Cancer trials listed on this page include Seattle, Olympia. Each trial page lists every participating site with contact details, so you can find the location closest to you.
Do I need insurance to join a Cancer clinical trial in Washington?
No. Study-related care is covered by the trial sponsor at no cost to participants, including the study treatment, required lab tests and study visits. Many Cancer trials in Washington also compensate participants for time and travel. Health insurance is not required to search or enroll.
How do I qualify for a Cancer clinical trial in Washington?
Each study sets its own criteria based on age, Cancer diagnosis details, prior treatments, current medications and general health. The fastest way to find out is to contact a research site directly — most will pre-screen you by phone in 10 to 15 minutes at no charge. You can also create a free TrialFinder profile to be matched automatically.
Will I get a placebo instead of cancer treatment?
Almost never. Cancer trials compare a new treatment with the current standard treatment, or add the study drug to standard treatment. When a placebo is used it is on top of standard care, and the consent form states this before you decide.
Can I join a cancer trial if my cancer has spread?
Yes. Many recruiting cancer trials are written for advanced or metastatic disease, including people whose earlier treatments have stopped working. The listing states the stage and prior treatments it accepts.
Do I have to stop my current cancer treatment to join a trial?
It depends on the trial. Some enroll people whose current treatment has stopped working, some add the study drug to the treatment you are on, and some are for people who have not started treatment yet. Ask the study team before changing anything.
Are Clinical Trials Safe? What Patients Should Know
How clinical trial safety works — phases, IRB oversight, informed consent, and your right to withdraw — plus the real risks and questions to ask.
How to Know If You Qualify for a Clinical Trial
Every trial has eligibility criteria based on diagnosis, age, and medical history. Here's how to tell if you qualify — and what to do if you're not sure.
Clinical Trials Without Insurance: What You Need to Know
Clinical trials cover the cost of study-related care, making them one of the few ways to access treatment without health insurance. Here's what's covered.
All guides →

Check Your Eligibility

Create a free profile and our AI will match you to Cancer trials near you in Washington.

Get Matched — Free
No insurance required

Breast cancer trials test new chemotherapy regimens, immunotherapy combinations, targeted therapies, and early-detection methods across all stages of breast cancer.

All Cancer trials →